Prevalence: Affects approximately 31.6 million Americans (10.1% of the population)
This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer
Probiotics (especially Lactobacillus rhamnosus) and vitamin D (1,000-2,000 IU/day) have the strongest evidence for...
Probiotics (especially Lactobacillus rhamnosus) and vitamin D (1,000-2,000 IU/day) have the strongest evidence for eczema, with meta-analyses showing reduced SCORAD severity scores. Omega-3 fatty acids and evening primrose oil may provide additional anti-inflammatory support.
Get the free evidence-based Eczema (Atopic Dermatitis) guide — delivered in 60 seconds.
No spam. Unsubscribe anytime.
Eczema (atopic dermatitis) affects approximately 31.6 million Americans, causing chronic itchy, inflamed skin. The condition involves immune dysregulation and impaired skin barrier function. Several supplements targeting inflammation, immune modulation, and skin barrier repair have shown benefit in clinical trials.
Eczema (atopic dermatitis) is a chronic inflammatory skin condition driven by a complex interplay between epidermal barrier dysfunction, immune dysregulation, and environmental triggers. The key pathological feature is a defective skin barrier — often linked to filaggrin gene mutations found in 20–30% of eczema patients — that allows allergens and irritants to penetrate the epidermis, triggering a Th2-dominant immune response with elevated IgE, IL-4, IL-13, and IL-31 (the "itch cytokine"). This creates an itch-scratch cycle that further damages the barrier. Ceramide deficiency in the stratum corneum leads to increased transepidermal water loss (TEWL), skin dryness, and vulnerability to Staphylococcus aureus colonization, which worsens inflammation. Standard treatment involves emollients, topical corticosteroids, and calcineurin inhibitors. Supplements targeting skin barrier repair, immune modulation, and inflammation reduction have some evidence as adjuncts, though the quality of trials is generally lower than for many other conditions.
Probiotics have the most studied evidence for eczema, particularly for prevention in high-risk infants. Kalliomaki et al. (2001) conducted a landmark RCT showing that Lactobacillus rhamnosus GG (LGG) given to mothers during late pregnancy and to infants for 6 months halved the incidence of eczema at age 2. A meta-analysis by Zuccotti et al. (2015) of 29 RCTs with over 6,000 participants confirmed that multi-strain probiotic supplementation during pregnancy and early infancy significantly reduced eczema incidence. For treating existing eczema, the evidence is more mixed — a meta-analysis by Kim et al. (2014) found modest benefits primarily in moderate-to-severe pediatric eczema with Lactobacillus-containing strains. Evening primrose oil (EPO) provides gamma-linolenic acid (GLA), which converts to the anti-inflammatory prostaglandin PGE1. Morse et al. (1989) found that high-dose EPO (6 g daily providing 480 mg GLA) significantly improved eczema severity scores, though a Cochrane review by Bamford et al. (2013) concluded the overall evidence was inconclusive due to study heterogeneity. Borage oil (providing higher GLA concentrations) showed mixed results in subsequent trials. Vitamin D supplementation has emerging evidence — Camargo et al. (2014) randomized 107 children with winter-related eczema to vitamin D 1,000 IU daily or placebo and found the vitamin D group had a 29% greater reduction in eczema severity (EASI score). Peroni et al. (2011) found that vitamin D levels inversely correlated with eczema severity. Fish oil (omega-3) has limited but suggestive evidence — Koch et al. (2008) found that higher maternal fish oil intake during pregnancy reduced infant eczema risk, and Soyland et al. (1994) showed modest improvements in adults with atopic dermatitis taking 6 g fish oil daily, though results across trials are inconsistent.
For probiotics, choose products containing Lactobacillus rhamnosus GG (LGG), Lactobacillus paracasei, or multi-strain combinations including Lactobacillus and Bifidobacterium species — these are the strains with the most eczema-specific evidence. Dose: at least 10 billion CFU daily. For prevention in high-risk infants, supplementation should begin in the third trimester (maternal) and continue through the first 6 months of life (infant), guided by a pediatrician. For evening primrose oil, high-dose supplementation (3–6 g daily) is needed to reach GLA levels used in positive trials — low-dose EPO products (500 mg–1 g) likely provide insufficient GLA. Borage oil is a more concentrated GLA source (20–24% GLA versus 8–10% in EPO). For vitamin D, 1,000–2,000 IU daily in children and 2,000–4,000 IU in adults, adjusted by blood levels. Winter supplementation is particularly important as eczema often worsens with reduced UV exposure. Third-party testing is important for all these supplements.
Biotin (vitamin H/B7) is often marketed for skin health but has zero evidence for eczema — its benefits are limited to the rare condition of biotin deficiency-related dermatitis. Zinc supplements, despite zinc's role in wound healing, have not demonstrated benefit for atopic dermatitis in controlled trials. Elimination diets and food sensitivity testing (IgG panels) are heavily promoted by alternative practitioners for eczema, but IgG food panels measure normal immune exposure and have no validated role in eczema management — the American Academy of Allergy, Asthma & Immunology explicitly recommends against them. True IgE-mediated food allergies do worsen eczema in some children, but this requires proper allergist evaluation, not supplement-based approaches. Collagen supplements have no evidence for eczema barrier repair. "Detox" supplements and liver cleansing programs marketed for skin conditions have no scientific basis in eczema pathophysiology. Sea buckthorn oil has preliminary positive data but from small, low-quality studies insufficient for recommendation.
For adjunctive eczema management: a multi-strain probiotic providing at least 10 billion CFU of Lactobacillus and Bifidobacterium species daily, vitamin D3 (2,000–4,000 IU daily, adjusted by blood level, particularly important in winter), and evening primrose oil or borage oil providing 400–500 mg GLA daily. For pregnant women with eczema-prone family history, begin probiotics in the third trimester for prevention. These supplements complement — not replace — proper moisturization (ceramide-containing emollients are first-line), trigger avoidance, and topical anti-inflammatory therapy. Allow 8–12 weeks for probiotic and GLA benefits to manifest. Omega-3 fish oil (1–2 g EPA+DHA daily) can be added for additional anti-inflammatory support. See /stacks/immune-resilience for overlapping immune-modulation strategies.
Supplements may support some aspects of skin barrier and inflammation in eczema but are not a substitute for medical evaluation, diagnosis, or clinician-directed care for atopic dermatitis. Seek urgent or emergency care for clusters of small painful blisters or punched-out erosions in an eczema flare with fever or malaise (possible eczema herpeticum, a serious viral skin infection that needs prompt medical care), spreading redness, warmth, swelling, or pus suggesting bacterial superinfection, fever with widespread rash, or any signs of severe allergic reaction (facial swelling, difficulty breathing, throat tightness). Book a dermatology or primary-care visit for eczema that is not controlled with basic moisturization and over-the-counter care, eczema that significantly disturbs sleep or daily function, frequent skin infections, sudden severe flares, eczema with food-allergy concerns (especially in young children), or any new or worsening rash. Evaluation may include skin exam, assessment of triggers (irritants, allergens, climate), patch testing for contact dermatitis when indicated, allergy referral when food or environmental allergy is suspected, and consideration of prescription topical or systemic therapy. Evidence-based care often includes consistent emollient use (especially ceramide-containing moisturizers), trigger avoidance, prescribed topical corticosteroids or calcineurin inhibitors, topical PDE-4 or JAK inhibitors when appropriate, and systemic biologic or oral therapy for moderate-to-severe disease; probiotics, omega-3, vitamin D, evening primrose oil, and zinc have been studied as adjuncts within that framework. Disclose all supplement use to your prescriber if you take immunosuppressants or biologics, are pregnant or breastfeeding, or are giving supplements to a child.
| # | Supplement | Typical Dose | Evidence | |
|---|---|---|---|---|
| 1 | Probiotics (Lactobacillus strains) | 10 billion CFU daily (L. rhamnosus GG) | Moderate | |
| See top probiotics (lactobacillus strains) picks → | ||||
| 2 | Omega-3 Fatty Acids | 1-2g EPA+DHA daily | Moderate | |
| See top omega-3 fatty acids picks → | ||||
| 3 | Vitamin D | 1,000-2,000 IU daily | Moderate | |
| See top vitamin d picks → | ||||
| 4 | Evening Primrose Oil | 2-4g daily (providing 160-320mg GLA) | Preliminary | |
| See top evening primrose oil picks → | ||||
| 5 | Zinc | 15-30mg daily | Preliminary | |
| See top zinc picks → | ||||
As an Amazon Associate, we earn from qualifying purchases. Some links below are affiliate links — this doesn't affect our editorial independence or product ratings. How we evaluate products
Seed PDS-08 Pediatric Daily Synbiotic
Seed
Nordic Naturals Ultimate Omega, Lemon Flavor - 90 Soft Gels - 1280 mg Omega-3 - High-Potency Omega-3
Nordic Naturals
Sports Research Vitamin D3 + K2 (5000 IU)
Sports Research
NOW Foods Evening Primrose Oil 1000mg
NOW Foods
Sports Research Triple Strength Omega-3
Sports Research
Yes. A 2018 meta-analysis of 25 RCTs found that probiotics, particularly Lactobacillus rhamnosus GG, significantly reduced SCORAD severity scores in both children and adults with atopic dermatitis. Probiotics appear to work by modulating the immune response and reducing systemic inflammation. Benefits are typically seen after 8-12 weeks of daily use at 10 billion CFU or more.
Evidence:Meta-analysis (2017) · 25 RCTs · moderate confidence[#1]. See full reference list below.Multiple studies support vitamin D for eczema management. A meta-analysis of 11 RCTs found that vitamin D supplementation (1,000-2,000 IU daily) significantly reduced eczema severity scores. Vitamin D enhances antimicrobial peptide production in the skin and modulates immune responses. Many eczema patients are vitamin D deficient, making supplementation particularly beneficial.
A comprehensive approach may include probiotics (10 billion CFU daily), vitamin D (1,000-2,000 IU), and omega-3 fatty acids (1-2g EPA+DHA). These target different aspects of eczema: probiotics modulate immune response, vitamin D strengthens skin barrier defense, and omega-3s reduce inflammatory prostaglandins. Evening primrose oil (GLA) may help with itch and skin hydration.
Probiotics are live beneficial bacteria that support gut health, immunity, and mood through the gut-brain axis. A 2018 meta-analysis found significant IBS symptom reduction with multi-strain probiotics. Benefits are strain-specific — choose based on your health goal. Typical dose: 10-50 billion CFU daily. Look for third-party tested products with verified potency through the expiration date.
Product Comparison